Skip to main content
. 2021 Jun 17;28(10):5793–5799. doi: 10.1016/j.sjbs.2021.06.028

Table 3.

comparison between migraine and control group through genetic models.

SNP Model Allele/
Genotype
Migraine
N = 127
%
Control
N = 120
%
P value Crude Analysis
COR(95% Cl)
¤Adjusted Analysis
AOR(95% Cl)
P value




rs2651899 (PRDM16)
Allele A 137(53.94) 188(78.33) <0.001*** 3.088(2.082–4.579)
G 117(46.06) 52(21.67)

Genotype
AA 34(26.77) 78(65)
AG vs. AA 69(54.33) 32(26.67) <0.001*** 4.947(2.766–
8.847)
5.452(2.983–9.965) <0.001***
GG vs. AA 24(18.90) 10(8.33) <0.001*** 5.506(2.376–12.760) 5.394(2.319–12.550) <0.001***
Dominant AA 34(26.77) 78(65)
AG + GG 93(73.23) 42(35) <0.001*** 5.080(2.951–8.744) 5.437(3.112–9.498) <0.001***


rs11172113 (LRP1)
Allele T 145(57.09) 166(69.16) 0.0055*** 1.686(1.165–2.441)
C 109(42.91) 74(30.83)

Genotype
TT 38(29.92) 53(44.16)
CT vs. TT 69(54.33) 60(50) 0.087 1.604(0.93–2.757) 1.749(0.996–3.073) 0.52
CC vs. TT 20(15.75) 07(5.84) 0.005** 3.985(1.582–10.369) 3.977(1.524–10.375) 0.005**
Dominant TT 38(29.92) 53(44.16)
CT + CC 89(70.08) 67(55.84) 0.021* 1.853(1.098–3.127) 2.028(1.180–3.487) 0.011*
rs10166942 (TRPM8) Allele T 189(74.41) 198(82.5) 0.0291* 1.621(1.048–2.508)
C 65(25.59) 42(17.5)

Genotype
TT 70(55.12) 84(70)
CT vs. TT 49(38.58) 30(25) 0.017* 1.960(1.126–3.411) 2.044(1.63–3.594) 0.013*
CC vs. TT 08(6.30) 06(5) 0.404 1.600(0.530–4.831) 1.484(0.489–4.511) 0.486
Dominant TT 70(55.12) 84(70)
CT + CC 57(44.88) 36(30) 0.016* 1.900(1.125–3.209) 1.943(1.143–3.305) 0.014*

Data presented as number (N) and percentage (%)

COR; Crude odds ratio, AOR; Adjusted odds ratio Cl; Confidence Interval

*p < 0.05, **p < 0.01, ***p < 0.001 statistically significant

Adjusted for age and sex